Risk factors for adrenal insufficiency after adrenalectomy for mild autonomous cortisol secretion

The clinical landscape regarding surgical management for mild autonomous cortisol secretion remains characterized by significant uncertainty. Prior research has shown that unilateral adrenalectomy improves various metabolic parameters in affected individuals. However, no prior work had resolved the exact frequency of postoperative adrenal insufficiency in this specific patient population. That uncertainty drove the need for a comprehensive evaluation of surgical outcomes. It was already known that cortisol suppression tests provide diagnostic value for autonomous secretion. Yet, the predictive power of these tests for subsequent hormonal deficiency after gland removal was unclear. This gap motivated a detailed retrospective investigation into patient cohorts. Clinicians currently lack standardized protocols for identifying those at highest risk for requiring long-term glucocorticoid replacement.

The study aimed to determine the incidence and identify risk factors for suspected adrenal insufficiency in patients undergoing unilateral adrenalectomy for mild autonomous cortisol secretion. This condition often presents diagnostic challenges for clinicians managing adrenal tumors. While surgical intervention improves metabolic health, the potential for postoperative hormonal deficiency remains a significant concern. No prior work had resolved the specific predictive value of preoperative testing for this complication. That uncertainty drove the researchers to evaluate a large cohort of patients. This investigation sought to clarify whether specific biochemical markers could forecast the need for glucocorticoid replacement. By analyzing data from 189 patients, the team intended to establish clearer guidelines for postoperative monitoring. This effort provides a foundation for improving patient safety and clinical management strategies in endocrine surgery.

The review approach involved a retrospective analysis of 189 adult patients who underwent unilateral adrenalectomy. Researchers identified participants based on specific biochemical criteria for mild autonomous cortisol secretion. The study excluded individuals diagnosed with adrenocortical carcinoma or overt Cushing syndrome. Investigators defined the primary outcome as a morning serum cortisol level below 10 μg/dL on the first day after surgery. Alternatively, the requirement for glucocorticoid replacement therapy also qualified as a positive event. The team employed multivariable logistic regression to evaluate potential predictors of the observed hormonal deficiency. This statistical model adjusted for patient age, sex, and circulating adrenocorticotropic hormone levels. The investigation focused on comparing preoperative dexamethasone suppression test results between groups with and without postoperative complications.

Key findings from the literature reveal that 48% of the total patient cohort developed suspected adrenal insufficiency after surgery. Among those with unilateral disease, the incidence reached 52.5%, compared to 24% in the bilateral group. The suspected insufficiency group exhibited significantly higher preoperative cortisol levels, with a median of 5.5 μg/dL versus 3.3 μg/dL in the unaffected group. Specifically, 71% of patients with preoperative cortisol levels above 5 μg/dL experienced postoperative insufficiency. Multivariable analysis demonstrated that these elevated preoperative levels correlate with a 4-fold increased risk of needing glucocorticoid replacement beyond one year. The median duration for glucocorticoid treatment among affected patients was 6 months. No significant differences appeared between groups regarding age, body mass index, or adrenocorticotropic hormone levels. These results establish preoperative cortisol suppression as a strong predictor for post-surgical hormonal status.

The authors suggest that suspected adrenal insufficiency occurs frequently following unilateral adrenalectomy for mild autonomous cortisol secretion. Synthesis and implications indicate that preoperative cortisol levels serve as a robust indicator for potential hormonal deficiency. Clinicians should prioritize these specific biochemical markers when planning postoperative care strategies. The data imply that patients with higher post-dexamethasone suppression test results require closer observation. This review approach highlights that monitoring duration should be tailored based on individual preoperative risk profiles. The researchers propose that these findings facilitate more informed clinical decision-making regarding glucocorticoid therapy. Their evidence supports the necessity of vigilant follow-up for those exceeding the five microgram per deciliter threshold. These insights provide a framework for managing potential complications in this surgical cohort.